The practice of continuous EEG monitoring (CEEG) in the Background: intensive care unit (ICU) has spread over the past decade. Building an effective ICU CEEG program demands adequate EEG equipment and human resources. This may not be available in developing healthcare systems. This study sought to shed light on the real-life utility of CEEG at a tertiary healthcare center in the developing healthcare system of Saudi Arabia. This is a retrospective review of CEEG findings, along with Methods: mortality and duration of hospitalization of patients who had CEEG during a 12-month period at the adult ICU at the King Abdulaziz University Hospital (KAUH) in Jeddah, Saudi Arabia.
Introduction
Continuous electroencephalography (CEEG), the practice of continuously recording an electroencephalogram and a timesynchronized video of the patient, is commonly utilized to monitor critically ill patients with acute brain injury or altered mental status 1 . CEEG is instrumental in the diagnosis and management of nonconvulsive seizures (NCS) and status epilepticus, detection of cerebral ischemia, prognostication of outcomes after cardiorespiratory arrest, and evaluation of abnormal movements and altered mental status 1 . The practice of CEEG monitoring of critically ill patients in the intensive care unit (ICU) has been spreading in Europe and North America over the past decade 1, 2 . Building an effective ICU CEEG program with sufficient quality demands not only adequate EEG equipment but also significant human resources 2 , including trained electroencephalographers and technologists with enough time to review large amounts of CEEG data 2 . While this is available in large tertiary care centers in North America and Europe where the practice of CEEG has developed, it may not be available in developing healthcare systems with constrained resources.
This study reviewed data generated from a CEEG program in the adult ICU at a tertiary healthcare center in Saudi Arabia, aiming to shed light on the real-life utility of CEEG in a developing healthcare system outside North America and Europe.
Methods

Data gathering
This is a retrospective review of ICU CEEG findings, as well as mortality status and duration of hospitalization of all patients who underwent CEEG monitoring during a 12-month period from September 2016 to August 2017 at the adult ICU at the King Abdulaziz University Hospital (KAUH) in Jeddah, Saudi Arabia. This is an academic, tertiary-care, 600-bed hospital. Its adult ICU is comprised of 30 beds and is divided into medical and surgical divisions. The average APACHE II (Acute Physiology and Chronic Health Evaluation II) score of medical patients admitted to the ICU ranges between 10-30 on average. The scores are routinely calculated but not recorded in the electronic medical records (EMR). ICU physicians or neurologists request CEEG to search for NCS or rhythmic or periodic patterns when critically ill patients have a disturbance in the level of consciousness that is unexplained by apparent underlying neurological or medical conditions. Some of these patients also exhibit paroxysmal motor or non-motor events in association with altered mental status (these are not always consistently recorded in the EMR upon requesting the EEG). During the study period, 120 patients had clinical seizures upon presentation. CEEG is initiated and stopped based on the clinical judgement of the treating physicians. Generally, physicians aim to continue CEEG monitoring for at least 24 hours in patients with altered mental status but may allow discontinuation of CEEG for clinical or practical constraints (e.g. EEG machine availability or the need to relocate a patient to conduct a procedure or test). The electroencephalographer reviews records at least once daily and communicates findings to the treating physicians. If seizures or other CEEG patterns of significance are revealed, physicians often decide to continue or repeat monitoring on subsequent days to guide management. For the purposes of this study, records that continue for several days and those that are within 60 days of each other were considered as one recording. EEGs with a duration that is less than 2 hours were not included in the study as they were considered extended but not long-term studies. An EEG technologist is available during the day time to set up ICU CEEGs. The time from requesting the CEEG to the beginning of the recording varied depending on availability of equipment and technologists. Generally, requests from the ICU are given priority and fulfilled within 24 hours but this is not always feasible. EEG leads are placed using the 10-20 international system of lead placement. CEEGs are digitally recorded, including synchronized video recording of the patient. An epileptologist with fellowship training in CEEG interpretation reviewed the records on daily basis and reported them using the American Clinical Neurophysiology Society (ACNS) ICU EEG consortium proposed nomenclature for ICU EEG reporting, and the Salzburg criteria for non-convulsive status epilepticus 3 .
Data analysis
Reports of CEEGs performed in the adult ICU during the study period were retrieved from the hospital's EMR. The author extracted key data, including background demographics, diagnoses, length of hospital stay, mortality status at 60 days after admission, and the presence of rhythmic and periodic patterns (RPPs) or NCS. Frequencies, percentages, means, standard deviation, and Chi square were performed using the IBM SPSS Statistics for Windows, version 20.0.
Ethical approval
This study was approved by the Institutional Review Board of KAUH as a retrospective study of anonymized clinical data with waiver of additional patient consent.
Results
A total of 202 CEEG records fulfilling the criteria were identified; complete, raw figures are available as Underlying data 4 . There were 116 female patients. The mean age was 53 years (standard deviation=21). The primary diagnosis (as defined by the ICU physicians and entered in the EMR and the EEG requisitions) was epilepsy in 53 patients (26.2%), ischemic stroke in 51 patients (25%), sepsis or metabolic derangement in 40 patients (19.8%), CNS infection in 24 patients (11.9%), intracranial hemorrhage in 10 patients (5%), post-cardiac arrests in 10 patients (5%), brain neoplasm in 8 patients (4%), and traumatic
Amendments from Version 2
This version of the article provides additional details in the Methods section about the clinical context and the practice setting from which the data have been collected. This includes details of patient selection and case identification. In addition, the author revised the statistical analysis of data concerning rhythmic and periodic CEEG patterns, revealing that having RPPs without non-convulsive seizures was not associated with negative outcomes in this study. Finally, the limitations of this retrospective study of data from a developing ICU CEEG program were better described. Figure 1 was updated for clarification.
Any further responses from the reviewers can be found at the end of the article brain injury in 6 patients (3%). The duration of CEEG recording varied, with 48 (24%) recorded for 2-6 hours and 154 (76%) recorded for longer. Figure 1 shows a flowchart demonstrating the frequencies of CEEG findings in the sample and their distribution over the outcome categories. There were 52 patients with NCS. Among them, 30 were of focal onset (57.7%) and 10 (5%) clearly fulfilled criteria for non-convulsive status epilepticus. There were 120 patients that had clinical seizures prior to CEEG monitoring. Among them, 36 (30%) had NCS on EEG. A total of 138 records showed RPPs, including 26 that had more than one RPP and 34 of the 52 records with NCS. A total of 78 records had only one type of RPP, including 22 (10.9%) with generalized periodic discharges (GPDs), 20 (9.9%) with lateralized periodic discharges (LPDs), 22 (10.9%) with generalized rhythmic delta activity (GRDA), and 14 (6.9%) with lateralized rhythmic delta activity (LRDA). Figure 2 shows EEG examples of LPDs and focal and generalized NCS. Sixty two patients (30.7%) out of the entire sample were deceased at 60 days after admission. This proportion was significantly higher in patients who had NCS than those who didn't (42% vs 27%, χ 2 = 4.4, df=2, p=0.03) ( Table 1 ). The frequency of NCS etiologies in the group that was deceased at 60 days is shown in Figure 1 . There was no statistically significant difference in mortality risk between the etiologies. There was no significant difference in the duration of hospital stay between those who had NCS and those who didn't (p=0.2) ( Table 1) . To analyze outcome data in relation to having RPPs, cases with RPPs but without seizures (a total of 104 cases) were considered. There was no statistically significant difference between the proportion of patients that were deceased at 60 days among those who had RPPs and the same proportion among those without relevant CEEG patterns (χ 2 = 0.8, df=2, p=0.2). Furthermore, there was no statistically significant difference between the two groups with regards to duration of hospitalization (χ 2 = 3.1, df=2, p=0.2) ( Table 1 ).
Discussion
The practice of using CEEG in the ICU has developed rapidly over the past decade, particularly in North America and Europe 1,5 . This study is one of the first to report the experience of using ICU CEEG in Saudi Arabia, a country with a rapidly developing healthcare system that faces economic constraints. The data are consistent with prior knowledge and experience from other countries that CEEG is effective in detecting NCS and other likely harmful subclinical EEG patterns 5, 6 . This study reveals statistically significant associations between NCS and mortality, supporting the clinical gestalt of identifying and treating potentially harmful CEEG patterns (although the interpretation of this finding is limited by the inability to control for illness severity and comorbidities in this study). Having RPPs without NCS was not associated with negative outcomes in this study. Furthermore, the potential incurred excess risks of morbidity and mortality in patients with NCS and RPPs was relatively modest. Such modest increases are not likely to be of clinical significance to clinicians evaluating patient prognoses. Nonetheless, this study was a retrospective study with limitations that preclude definitive conclusions about morbidity and mortality risk magnitudes. These are better assessed by prospective studies and in well-developed CEEG programs.
Prior studies have not definitively proven that utilizing CEEG leads to better outcomes 2,5 . This, coupled with the significant resources required to effectively run an ICU CEEG program 2 , may lead decision makers in developing healthcare systems to hesitate to support the development of CEEG practices and research. This study presents data from a small and developing program to demonstrate real-world effectiveness of CEEG in detecting potentially harmful electrophysiological patterns. In addition, the study highlights the uncertainties regarding the clinical significance of the prognostic information provided by CEEG. Hopefully, this should lead to further development of ICU CEEG programs with embedded prospective, patientcentered research programs. Such research should focus on how CEEG may be used effectively and optimally and how the generated data may impact clinical decisions and patient outcomes in the ICU.
This study is a retrospective analysis with limitations. Retrospective EMR data did not contain accurate information with regards to the extent and evolution of mental status changes relative to the timing of the CEEG changes, use and titration of sedatives, and other management decisions. Data concerning illness severity were also not recorded in the EMR, limiting the feasibility of controlling for illness severity and comorbidities during the analysis. As such, it cannot be ruled out that differences between groups were in part due to differences in illness severity. It was difficult to ascertain the timing of EEG initiation in relation to these dynamic variables of interest. Physicians did not follow a clear protocol when deciding the duration of the CEEG study. Furthermore, a selection bias is introduced because of the lack of EEG technologists at night. Shortages in machines and technicians may have affected the duration of CEEG monitoring, as well as treatment decisions and outcomes. Longer studies may lead to higher detection rates of relevant CEEG patterns. Although the total number of cases was 202, the number of cases in most diagnostic categories was not high enough to permit subgroup analyses. The lack of significant associations between negative outcomes and the presence of RPPs without NCS should be interpreted with caution since our data lumped all types of RPPs together and was not sufficiently powered to study each subtype of RPPs. Finally, the clinical setting of this study is that of a developing program with limited resources and must be interpreted in this context. Further studies from developing healthcare systems like Saudi Arabia's are needed to illuminate how the practice of CEEG monitoring may be best utilized to provide clinically meaningful data while caring for patients in the ICU.
Data availability
Open This project contains all raw de-identified data associated with this study.
Data are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).
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Yara Mikhaeil-Demo
University of Illinois at Chicago, Chicago, USA Elizabeth E Gerard Department of Neurology, Feinberg School of Medicine, Northwestern University (NU), Chicago, IL, 60611, USA This paper describes a one-year experience using continuous EEG monitoring in a developing healthcare system. The authors experience with a growing cEEG program is a valuable addition to the literature. We have some comments and questions to better understand the results described:
Methods:
What were the inclusion and exclusion criteria? Was EEG duration less than two hours the only exclusion criteria?
How frequently were studies reviewed and results communicated to treating team? It would be helpful to know the timing of when the seizure occurred on EEG and the identification of these findings on EEG and communication with the treating physician.
When discussing mortality and morbidity, it would be helpful to adjust for comorbid conditions and severity of underlying illness.
In the statistical analysis were p values adjusted for multiple comparisons?
Results:
The author indicates a total of 202 cEEG records were identified. Are these for 202 unique patients? Did any patients have more than one cEEG study during this time? If so, were the subsequent studies excluded if the patients had more than one cEEG study during the one year period?
How were the clinical diagnoses defined? For example, was "epilepsy" used only if the patient had a prior diagnosis of epilepsy or was it also used for new-onset seizures? Subcategorization of "cerebrovascular disease" would also be helpful. (Based on prior studies intracranial hemorrhage is much more likely to be associated with seizures than ischemic strokes.)
In addition to describing the primary diagnosis of the patients it would be helpful to know why they were connected to cEEG. What were the indications for EEG monitoring and frequency for each indication? It would be helpful to describe a table of indication for EEG monitoring and percentage for each reason (example, clinical seizure, altered mental status. abnormal movements, etc).
Discussion:
Without adjusting for underlying diagnosis and comorbidities, it is difficult to claim that there is "a 1.
2.
3.
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Without adjusting for underlying diagnosis and comorbidities, it is difficult to claim that there is "a significant association between NCS and mortality".
It would be helpful to provide a more detailed discussion as to why the following finding was noted "periodic or rhythmic patterns was significantly associated with longer hospital stays."
In the method section, the author states: "The duration of CEEG monitoring is decided by the neurology consultation or ICU physicians." It appears that the longest duration for a study was 24 hours; however, as mentioned 52 patients had nonconvulsive seizures, with 10 patients fulfilling the criteria for non-convulsive status epilepticus. How were these patients monitored for response to treatment? Were NCS and NCSE successfully treated by the time of disconnect?
Throughout the article the authors refer to the resource requirement for CEEG monitoring. It would be interesting to know if and how resource limitations affected monitoring. What was the time from request to connection? Is there any reason to suspect this affected outcomes? Figures: Figure 2 is labeled "examples of patterns on the ictal interictal continuum;" however, clear interictal and ictal patterns are shown under this legend. Tables: Table 1 Title has the words "on cEEG" twice.
Is the work clearly and accurately presented and does it cite the current literature? Yes
Is the study design appropriate and is the work technically sound? Yes
Are sufficient details of methods and analysis provided to allow replication by others? No
If applicable, is the statistical analysis and its interpretation appropriate? I cannot comment. A qualified statistician is required.
Are all the source data underlying the results available to ensure full reproducibility? Partly
Are the conclusions drawn adequately supported by the results? Partly
No competing interests were disclosed.
Competing Interests:
We confirm that we have read this submission and believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however we have significant reservations, as outlined above. Thank you so much for taking the time to review the second version of the manuscript and for your valuable comments that have helped me improve it. I have responded to your comments below, point by point.
Methods:
1. What were the inclusion and exclusion criteria? Was EEG duration less than two hours the only exclusion criteria? Indeed, we included all patients who had CEEG and only excluded cases that did not last for more than 2 hours.
2. How frequently were studies reviewed and results communicated to treating team? It would be helpful to know the timing of when the seizure occurred on EEG and the identification of these findings on EEG and communication with the treating physician. Thank you for pointing this was not explained. I added this statement in the methods section (line 38 of the manuscript): "The electroencephalographer reviewed records at least once daily and communicated findings to the treating physicians. If seizures or other CEEG patterns of significance are revealed, physicians often decided to continue monitoring on subsequent days to guide management."
3. When discussing mortality and morbidity, it would be helpful to adjust for comorbid conditions and severity of underlying illness. Thank you for pointing out the importance of controlling for comorbid conditions and illness severity. As stated in the Methods section (line 26 of the manuscript): "The average APACHE II (Acute Physiology and Chronic Health Evaluation II) score of medical patients admitted to the ICU ranges between 10-30 on average. The scores are routinely calculated but not recorded in the electronic medical records (EMR)." As illness severity scores were not recorded in the EMR, the author had no feasible way to control for it during analysis. I added the following statement in the limitations section in the discussion (line 150 of the manuscript): "Data concerning illness severity were also not recorded in the EMR, limiting the feasibility of controlling for illness severity and comorbidities during the analysis. As such, it cannot be ruled out that differences between groups were in part due to differences in illness severity". 4. In the statistical analysis were p values adjusted for multiple comparisons? The p value was appropriate for the number of comparators and is stated for each analysis.
Results
1. The author indicates a total of 202 cEEG records were identified. Are these for 202 unique patients? Did any patients have more than one cEEG study during this time? If so, were the subsequent studies excluded if the patients had more than one cEEG study during the one year period? Thank you for pointing this needed to be clarified. I added the following to the Methods section (line 41 of the manuscript): "For the purposes of this study, records that continue for several days and those that are repeated during the same hospitalization or within 60 days of each other were considered as one recording." This was also clarified in the results section (line 74). The outcome of mortality within 60 days and length of hospitalization were defined in relation to the cEEG records defined as such.
2. How were the clinical diagnoses defined? For example, was "epilepsy" used only if the patient 2. How were the clinical diagnoses defined? For example, was "epilepsy" used only if the patient had a prior diagnosis of epilepsy or was it also used for new-onset seizures? Subcategorization of "cerebrovascular disease" would also be helpful. (Based on prior studies intracranial hemorrhage is much more likely to be associated with seizures than ischemic strokes.) The primary clinical diagnosis was defined by physicians taking care of the patient and entered in the EEG requisition. This is now stated results section (line 68 of the manuscript). With regards to the breakdown of cerebrovascular disease, there were 10 cases of intracranial hemorrhage. This is now stated in line 71 of the manuscript.
3. In addition to describing the primary diagnosis of the patients it would be helpful to know why they were connected to cEEG. What were the indications for EEG monitoring and frequency for each indication? It would be helpful to describe a table of indication for EEG monitoring and percentage for each reason (example, clinical seizure, altered mental status. abnormal movements, etc). All patients had altered mental status. There was no reliable record of associated paroxysmal motor or non-motor events, barring the ability to provide that. This is now stated in line 31-34 of the manuscript.
Discussion: 1. Without adjusting for underlying diagnosis and comorbidities, it is difficult to claim that there is "a significant association between NCS and mortality". I now added this statement in the Discussion section (line 129 of the manuscript): ... although the interpretation of this finding is limited by the inability to control for illness severity and comorbidities in this study.
2. It would be helpful to provide a more detailed discussion as to why the following finding was noted "periodic or rhythmic patterns was significantly associated with longer hospital stays." Following the advice of another reviewer, the manuscript now presents data of RPPs without NCS, showing no association with hospital stay. The statement in question is now removed and replaced with the following: "Having RPPs without NCS was not associated with negative outcomes in this study" (line 130 of the manuscript).
3. In the method section, the author states: "The duration of CEEG monitoring is decided by the neurology consultation or ICU physicians." It appears that the longest duration for a study was 24 hours; however, as mentioned 52 patients had nonconvulsive seizures, with 10 patients fulfilling the criteria for non-convulsive status epilepticus. How were these patients monitored for response to treatment? Were NCS and NCSE successfully treated by the time of disconnect? Thank you for pointing out the need for clarification here. This is now clarified in the methods section as follows: "Generally, physicians aim to continue monitoring for at least 24 hours in patients with altered mental status but may allow discontinuation of CEEG for clinical or practical constraints (e.g. EEG machine availability or the need to relocate a patient to conduct a procedure or test). The electroencephalographer reviewed records at least once daily and communicated findings to the treating physicians. If seizures or other CEEG patterns of significance are revealed, physicians often decided to continue monitoring on subsequent days to guide management. For the purposes of this study, records that continue for several days and those that are repeated during the same hospitalization or within 60 days of each other were considered as one recording." 4. Throughout the article the authors refer to the resource requirement for CEEG monitoring. It would be interesting to know if and how resource limitations affected monitoring. What was the time from request to connection? Is there any reason to suspect this affected outcomes? 1.
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time from request to connection? Is there any reason to suspect this affected outcomes? Thank you for pointing this out. I added this to the Methods section: "The time from requesting the CEEG to the beginning of the recording varied depending on availability of equipment and technologists. Generally, requests from the ICU are given priority and fulfilled within 24 hours but this is not always feasible." I also added this to the limitations section to emphasize this point: "Shortages in machines and technicians may have affected duration of CEEG, treatment decisions and outcomes." (line 158 of the manuscript). Thank you both very much for your time reviewing this manuscript and making it better.
Sincerely, Haythum Tayeb
Competing Interests:
Page 5, line 2 of Figure 2 legend: please change "uV" to the appropriate abbreviation for "microvolts". Major:
I think that Table 1 needs to be corrected. For example, if you consider the top 6 rows related to NCS and check the numbers against the data in Figure 1 there appears to be an inconsistency. For example, row 4 tells us the number of cases with NCS as dead/alive, and by duration <1w/1w-1m/>1m. Cross-checking with Figure 1 the sub-totals for cases with NCS should add-up to 52/202, and of the 52, 22 died and 30 were alive at 60 days (22+30 = 52), which is correct. There is a problem in row 1 (the cases not exhibiting NCS). The total here should be 150 (ie, 202 minus 52). Indeed, for mortality the dead/alive (40 + 110) adds-up to 150. However, in the <1w/1w-1m/>1m three-way split, the total (44 + 60 + 44) adds-up to 148, and so 2 cases are missing. Please
2.
three-way split, the total (44 + 60 + 44) adds-up to 148, and so 2 cases are missing. Please recheck the numbers and percentages, and the statistical tests as described in the text to make sure that everything is correct.
Again, Table 1 , but now the bottom 6 rows related to RPPs. If you cross-check the numbers against the data in Figure 1 there appears to be some inconsistencies. For example, row 4 (row 10 in the Table) tells us the number of cases with RPPs as dead/alive, and by duration <1w/1w-1m/>1m. Cross-checking with Figure 1 the sub-total of cases with RPP should add-up to 104. however, in the dead/alive split we have 46 + 92 = 138 (so an extra 34 cases). In the <1w/1w-1m/>1m three-way split, the total (30 + 62 + 46) also adds-up 138 (again an extra 34 cases). I think, based on the data in Figure 1 , the three-way split (<1w/1w-1m/>1m) should in fact be 26+46+32=104. Then, the first row of this subsection (row7 in the Table) then needs to be adjusted, and the statistics rechecked. Thank you for the extra work in doing this -making sure that number are accurate and consistent is always a hard task.
Is the work clearly and accurately presented and does it cite the current literature? Partly
Is the study design appropriate and is the work technically sound? Partly
Are sufficient details of methods and analysis provided to allow replication by others? Partly
If applicable, is the statistical analysis and its interpretation appropriate? Partly
Are the conclusions drawn adequately supported by the results? Partly
Competing Interests:
Reviewer Expertise: Pediatric Neurocritical Care; Pediatric ICU Thank you for pointing out the discrepancy between the table and the flowchart. This discrepancy in the part of the table with data regarding RPPs was because the numbers represented all cases with RPPs (including those who had NCS as well, a total of 138 cases indeed). There was also a typographical error row 1.
I confirm that I have read this submission and believe that I have an appropriate level of expertise to state that I do not consider it to be of an acceptable scientific standard, for reasons outlined above.
Following your recommendation and realizing the importance of separating RPPs from NCS, I made the following changes:
1. I fixed the typographical error in row 1 of the table (60 was changed to 62). 2. I replaced the prior numbers in the last 6 rows of the table with the numbers of cases with RPPs without NCS. When these cases are considered, the association between RPPs and length of hospital stay drops out of significance. Accordingly, I adjusted that in the abstract, results, and discussion sections as well. 3. I changed the flowchart slightly to clarify that that the 52 cases of NCS include cases that also had RPPs.
Once again, thank you for your valuable time, effort, and insights.
Sincerely, Haythum Tayeb
No competing interests were disclosed. Competing Interests:
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If applicable, is the statistical analysis and its interpretation appropriate? Partly
Are the conclusions drawn adequately supported by the results? Partly
Competing Interests:
Reviewer Expertise: EEG I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.
3.
Results:
The author indicates a total of 202 cEEG records were identified. Are these for 202 unique patients? Did any patients have more than one cEEG study during this time? If so, were the subsequent studies excluded if the patients had more than one cEEG study during the one-year period?
How were the clinical diagnoses defined? For example, was "epilepsy" used only if the patient had a prior diagnosis of epilepsy, or was it also used for new-onset seizures? Subcategorization of "cerebrovascular disease" would also be helpful. (Based on prior studies intracranial hemorrhage is much more likely to be associated with seizures than ischemic stroke.)
For Table 2 , did any patients have more than one of the periodic patterns? Did patients have NCS and periodic patterns? Why is NCSE not listed in the table?
It would be interesting to look at the diagnoses associated with NCS, NCSE and periodic patterns.
Discussion:
The author states: "The data are consistent with prior knowledge and experience from other countries that CEEG is effective in detecting NCS and other likely harmful subclinical EEG patterns on the ictal-interictal continuum." This paper does not define nor discuss the ictal-interictal continuum.
The discussion should compare the findings at the current center to prior publications on the yield of CEEG.
Without adjusting for underlying diagnosis and comorbidities, it is difficult to claim that there is "a significant association between NCS and mortality."
Throughout the article the authors refer to the resource requirement for CEEG monitoring. It would be interesting to know if and how resource limitations affected monitoring. What was the time from request to connection? Is there any reason to suspect this affected outcomes?
Is the work clearly and accurately presented and does it cite the current literature?
2.
Is the work clearly and accurately presented and does it cite the current literature? Partly
Is the study design appropriate and is the work technically sound? Partly
Are sufficient details of methods and analysis provided to allow replication by others? Partly
If applicable, is the statistical analysis and its interpretation appropriate? Partly
Are the conclusions drawn adequately supported by the results? Partly
Competing Interests:
We confirm that we have read this submission and believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however we have significant reservations, as outlined above.
Robert C. Tasker
Department of Neurology, Harvard Medical School, Boston, MA, USA The author has described a practice of continuous EEG monitoring in an intensive care unit in a University Hospital in Jeddah, Saudi Arabia.
I have a number of comments that will help readers better understand what these data mean, and how they might reflect on the implications for ICU practice.
(page 3) Method
In the first paragraph (line 8) the author describes "CEEG are requested by ICU physician or neurologists according to the clinical needs". In order to understand the significance of some of the analyses provided, it would be helpful to know what were the inclusion criteria, or the 'standard operating procedure' for the ICU. For example, were all patients comatose, and the clinician was unable to assess a clinical response?
In the first paragraph (lines 13-15) the authors describes "The duration of CEEG monitoring is 2.
Since this population has been gathered from ICU admissions, it would be helpful to have some description of ICU severity-of-illness, according to the risk-adjustment score used by the unit. The examination of any illness feature that might be associated with death needs to be adjusted for severity of illness. There were 62 observed deaths in 200 cases -what was the expected number of deaths from the admission data? (pages 3 and 4)
Results
The presentation of findings in the Results section and the Abstract is a little confusing:
The author has a starting population of 202 patients undergoing CEEG monitoring. Then, the denominators being used in the data summaries are n=120, and n=200. I think that a flow chart would help here. Table 2 can be summarized as text, which will make room for a flow-diagram and better review of the data presented in Table 3 . Table 3 needs some attention to data accuracy. For example, in Row 2 (Hospital stay data) the percentages add up to 101%, which is just a rounding error. In Row 3 (Hospital stay data) the percentages add up to 99%.
Yes, the author has found some associations with death, and length of stay, but does the information gained from CEEG have the potential to help with decision making? For example, if we imagined that CEEG was a 'diagnostic test', then:
The pre-CEEG probability of death in this population was 31%. The finding of EEG-seizures could change your pre-test to a post-test probability of death of 39%. I don't think that physicians would find this a helpful piece of information. That is, it is not about death, rather it is something we should use to identify a need for treatment, for example. Similarly, the pre-CEEG probability of hospital stay >1 month was 32%. The finding of periodic or rhythmic patterns could change the pre-test to post-test probability of hospital stay >1 month to 34%. Again, I don't think that physicians would find this a helpful piece of information.
Obviously, both of these points would need to be tested and validated in a prospective study (as well as knowing details of when these CEEG features were found), but it may lead to a change in emphasis in the first paragraph of the Discussion.
(pages 3 and 4) Discussion
Based on the above results, one could conclude that identifying EEG seizures on CEEG does not provide a significant 'quantum' in prognostic evidence. Similarly, identifying periodic or rhythmic patterns on CEEG does not provide a significant 'quantum' in identifying cases that will be likely be in-hospital >1 month.
I am wondering whether the focus should be on 'what are we doing the CEEG': surely it is to identify something that we can/should treat; and, to identify something that will help us determine that we no longer need to do CEEG. continue monitoring for 24 hours in patients with altered mental status but may allow discontinuation of CEEG for clinical or practical constraints (e.g. EEG machine availability or the need to relocate the patients)." In this developing program, there is no hospital protocol with regards to patient selection, CEEG initiation or termination. This is entirely left to the discretion of the treating physicians and is typically reached through discussion and consultation between neurology and ICU. Generally, all patients with unexplained altered mental status were included. It was difficult to ascertain from the EMR documentation how the mental status evolved during the time of the CEEG, unfortunately. This is a limitation I state in the Discussion section.
2. In order to understand the significance of some of the analyses later in the manuscript, it would be helpful to know when CEEG was started and finished in relation to admission and discharge/death. It would also be helpful to know the timing of when NCS occurred. It was difficult to determine with consistency retrospectively from EMR how the duration of monitoring was decided and when the seizures occurred relative to the outcomes of interest. I agree that this is a limitation and would be best addressed in a prospective study. I added this to the new version of the article in the discussion section: "Retrospective EMR data did not contain accurate information with regards to the extent and evolution of mental status changes relative to the timing of the CEEG, use and titration of sedatives, and other management decisions. It was difficult to ascertain the timing of EEG initiation in relation to these dynamic variables of interest. Physicians did not follow a clear protocol when deciding the duration of the CEEG study."
3. Since this population has been gathered from ICU admissions, it would be helpful to have some description of ICU severity-of-illness, according to the risk-adjustment score used by the unit. The examination of any illness feature that might be associated with death needs to be adjusted for severity of illness. There were 62 observed deaths in 200 cases -what was the expected number of deaths from the admission data? Thank you for pointing this out. I added this to the methods section: "The average APACHE II (Acute Physiology and Chronic Health Evaluation II) score of medical patients admitted to the ICU ranges between 10-30 on average. The scores are routinely calculated but not recorded in the electronic medical records (EMR)." This was a limitation of the study and we could not remedy this by calculating scores retrospectively. 4 . The author has a starting population of 202 patients undergoing CEEG monitoring. Then, the denominators being used in the data summaries are n=120, and n=200. I think that a flow chart would help here. I added a flow chart. Thank you for suggesting it. n=120 is the number of patients who had clinical seizures prior to CEEG initiation. This is a group of interest since data have previously shown ã 30% risk of NCS. We replicated this. I removed n=200 from the prior reporting of the Chi-square to avoid ambiguity. Thank you. Table 2 can be summarized as text, which will make room for a flow-diagram and better review of the data presented in Table 3 . Done. I expanded table 1 (formerly table 3 ) by adding row and column percentages. 6 . Table 3 needs some attention to data accuracy. Thank you for pointing this out. I scrutinized the data and ensured accuracy. I fixed several coding errors that altered the proportions slightly without altering the overall outlook of the results as well.
5.
7. Does the information gained from CEEG have the potential to help with decision making? 7. Does the information gained from CEEG have the potential to help with decision making? Thank you very much for highlighting this issue. To address it, I reported the "pre-test" proportions to show that the "post-test" proportions are not of large magnitudes. I also added row and column percentages in table 1. 8. I am wondering whether the focus should be on 'what are we doing the CEEG': surely it is to identify something that we can/should treat; and, to identify something that will help us determine that we no longer need to do CEEG. Thank you for this insight. I altered the discussion to reflect the uncertainty about the clinical meaningfulness of the prognostic information and highlight the need for prospective studies to address the important questions. This is from the new version of the manuscript: "This study reveals statistically significant associations between NCS and mortality and between RPPs and longer hospital stays, supporting the clinical gestalt of identifying and treating potentially harmful CEEG patterns is worthwhile. However, the incurred excess risks of morbidity and mortality in patients with NCS or RPPs was relatively modest. Such modest increases are not likely to be of clinical significance to clinicians evaluating patient prognoses. Nonetheless, this study was a retrospective study with limitations that preclude definitive conclusions about morbidity and mortality risk magnitudes, which are better assessed with prospective studies and in well-developed CEEG programs. Prior studies have not definitively proven that utilizing CEEG leads to better outcomes . This, coupled with the significant resources required to effectively run an ICU CEEG program , may lead decision-makers in developing healthcare systems to hesitate to support the development of CEEG practices and research. This study presents data from a small and developing program to demonstrate the real-world effectiveness of CEEG in detecting potentially harmful electrophysiological patterns. In addition, the study highlights the uncertainties regarding the clinical significance of the prognostic information provided by CEEG. Hopefully, this should lead to further development of ICU CEEG programs with embedded prospective, patient-centered research programs. Such research should focus on how CEEG may be used effectively and optimally and how the generated data may impact clinical decisions and patient outcomes in the ICU."
Once again, thank you very much for your thorough review of this manuscript and your valuable insights. Much appreciated.
Sincerely, Haythum Tayeb
